CASP3 and epilepsy: Administration of chondroitin sulfate concluded a significant and dose-dependent attenuation of pentylenetetrazole- and pilocarpine-induced seizures in mice. Additionally, chondroitin sulfate suppressed levels of caspase-3, showed its antioxidant and anti-inflammatory properties, indicating a neuroprotective treatment strategy in epilepsy.